Obstructive Sleep Apnea-hypopnea Syndrome

• CLINICAL_TRIALS trial_result · 2011-01-26
  Clinical Trial Update: Extension Study of Original Protocol AERO C009 for Obstructive Sleep Apnea-hypopnea

  Extension study update for the original protocol AERO C009 in obstructive sleep apnea-hypopnea; the trial status is completed.

• FDA approval · 2010-10-21
  FDA Approved: MODAFINIL — Supplemental Application (CIMA LABS INC.)

  FDA approved a supplemental application for modafinil submitted by CIMA Labs, resulting in changes to the drug's labeling.

• CLINICAL_TRIALS trial_result · 2010-07-13
  Clinical Trial Update: Evaluation Of Patients With Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS) Based on Nonlinear Analysis Of Respiratory Signals

  The trial evaluating nonlinear analysis of respiratory signals in patients with obstructive sleep apnea-hypopnea syndrome has completed.

• CLINICAL_TRIALS trial_result · 2010-02-03
  Clinical Trial Update: Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea (OSA/H) Syndrome [Phase 3]

  Phase 3 trial update for armodafinil in excessive sleepiness associated with obstructive sleep apnea-hypopnea syndrome, with results posted …

• FDA approval · 2007-06-15
  FDA Approved: NUVIGIL — Original Application (Cephalon, LLC)

  FDA approved NUVIGIL (armodafinil) in its original application from Cephalon, LLC. It is approved for excessive daytime sleepiness associate…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2006-08-01
  Clinical Trial Update: REMStar Auto With C-Flex - In-Laboratory Performance v. Conventionally Titrated CPAP Therapy: Performances and Preferences [NA]

  A completed clinical trial comparing REMStar Auto with C-Flex CPAP therapy to conventionally titrated CPAP in-laboratory performance and use…